12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sulfur Colloid injection regulatory update

FDA approved an expanded label for Pharmalucence's Sulfur Colloid injection to include localizing lymph nodes in patients with malignant melanoma. FDA also granted Orphan Drug...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >